Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02066662
Recruitment Status : Active, not recruiting
First Posted : February 19, 2014
Last Update Posted : August 21, 2019
Sponsor:
Collaborator:
Bayer
Information provided by (Responsible Party):
RWTH Aachen University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : March 2020
Estimated Study Completion Date : March 2020